As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: December 23, 2016
by Joana Fernandes PhD Alzheimer’s News Today:
Treatment with the antibiotic Rocephin (ceftriaxone) may restore brain function in areas affected by Alzheimer’s disease, according to new research.
The study, “Mapping Synaptic Glutamate Transporter Dysfunction In Vivo To Regions Surrounding Aβ Plaques By Iglusnfr Two-Photon Imaging,” was published in the journal Nature Communications.
The hallmark of Alzheimer’s disease is the production of beta-amyloid protein plaques, which accumulate in neurons, disrupting their activity and communication.
Researchers found that in brain areas where beta-amyloid protein plaques are present there also is an increased amount of glutamate (a molecule that neurons use to send signals among each other to communicate) and increased activity of glial cells, which surround and support neurons. These alterations promote dysregulated neuronal activity and cause neuronal damage and loss in advanced stages of the disease.
Previous studies have shown that the antibiotic Rocephin was able to improve glutamate transport, and prevent its accumulation, in neurons. Thus, researchers administered the antibiotic to mice with Alzheimer’s disease. Results showed that, indeed, Rocephin resolved the accumulation of glutamate and restored its levels to normal, subsequently improving neuronal communication in areas affected by the plaques.
“By imaging the glial cells and glutamate itself around the plaques, we were able to see that the cells were not able to ‘remove’ the glutamate accumulating in these brain areas. By using [Rocephin], we were able to [increase] glutamate transport,” Brian MacVicar, PhD, the study’s senior author, said in a press release. “By restoring glutamate levels, we were able to mostly restore neuronal activity.”
The team believes that targeting the toxic accumulation of glutamate in neurons affected by beta-amyloid plaques may be a promising strategy to treat the early symptoms of Alzheimer’s disease.
“This dysfunction in cell communication occurs at a very early stage in the disease, before memory impairment is detectable,” said Jasmin Hefendehl, PhD, the first author of the study. “This makes our discovery particularly interesting, as it opens a window for an early intervention strategy to possibly prevent or delay neuron and memory loss.”
Rocephin in an FDA-approved antibiotic that is frequently prescribed to treat several bacterial infections, such as meningitis, pneumonia or skin infections, and to prevent the development of bacterial infections before certain surgeries.
As scientists continue to try understand Alzheimer’s and how it might be cured, new research has uncovered an intriguing link between the condition and some degenerative eye diseases, including glaucoma. While it’s much too...
Feeling dizzy or lightheaded when you stand up may be a risk factor for stroke and dementia years down the road, a new study reports. The condition, known as orthostatic hypotension, is...
Healthcare providers and researchers rely on screening questions to detect patients who may be at risk for developing Alzheimer’s disease and other aging-related problems, but how these questions are worded may be confusing or trigger emotional responses....
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.